CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
      • Collink.3D 50
      • Collink.3D 50L
      • Collink.3D 90
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Sustainability
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Apr 12, 2018 6:55am EDT

CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer

Mar 21, 2018 6:45am EDT

CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update

Feb 21, 2018 6:00am EST

CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs

Jan 31, 2018 11:55am EST

CollPlant Announces ADS Listing on NASDAQ

Jan 16, 2018 6:00am EST

CollPlant Appoints David Tsur as Chairman of the Board

Nov 28, 2017 12:43pm EST

CollPlant Receives Substantial, Repeat Order for Its Biological Ink

Nov 28, 2017 8:35am EST

CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix®FG for Treatment of Acute and Chronic Wounds and Surgical Cuts

Nov 13, 2017 3:00am EST

Vote of Confidence in CollPlant: Completion of Agreement for Immediate Investment of USD 1.1 Million from Ami Sagi, one of the Company's Largest Shareholders

Oct 30, 2017 10:03am EDT

Innovation Authority Gives Vote of Confidence: CollPlant Receives Innovation Authority Approval for USD One Million R&D Program with 40% Funding

Sep 11, 2017 7:18am EDT

CollPlant Signs Definitive Agreement for $5 Million Private Placement with US Investor

RSS
  • Prev
    • 1...
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2025 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20